is a characteristic of cancer cells. Since a coordinated interaction of epithelial tumor cells with stromal cells is a prerequisite for tumor invasion and metastasis, the present study was designed to test the hypothesis that skin-derived tumor cells may modulate homologous and heterologous GJIC. While homologous GJIC of human dermal fibroblasts as well as epidermal keratinocytes was detected, no communication was measured between SCL-1 cells derived from squamous cell carcinoma of human skin. Interestingly, co-cultures of dermal fibroblasts and SCL-1 tumor cells in serum-containing medium resulted in a 52±70% lowering of the number of communicating fibroblasts. Furthermore, incubation of confluent fibroblast cultures with serum-free supernatant fractions (20±30 kDa) from tumor cells, termed the 20/30 fraction, lowered the homologous gap junction communication of fibroblasts by 490%. This novel aspect of down-regulated homologous GJIC of dermal fibroblasts, which is reversible, was neither mediated by alteration of the expression of connexin43, the major gap junctional protein of dermal fibroblasts, nor by aberrant localization of connexin43 in the plasma membrane. Furthermore, post-translational modifications of connexins, such as phosphorylation, was not measured by mobility shift studies. Tumor cell-mediated GJIC down-regulation between fibroblasts was suppressed using EGTA-containing serum-free tumor cell-derived supernatants suggesting that calcium ions (Ca 2 ) might mediate the transduction of this effect. The involvement of Ca 2 in down-regulation of homologous GJIC of fibroblasts was supported by an increase in fluorescence intensity of the intracellular calcium-sensitive indicator Fura-2 upon treatment of fibroblasts with the active 20/30 fraction. In conclusion, these data establish homologous GJIC of (stromal) fibroblasts as a parameter modulated by a paracrine acting factor(s) of epithelial tumor cells during tumor±stroma interaction of skin cells.
Introduction
The UVB radiation-mediated incidence of non-melanoma skin cancers (photocarcinogenesis), including squamous cell carcinoma (SCC) and basal cell carcinoma, has increased dramatically over recent decades, reaching epidemic proportions (1, 2) .
(Skin) cancer is generally thought to be the result of disruption of the homeostatic regulation mediated by a complex set of stage-specific genetic and epigenetic changes, subsequently leading to hyperproliferation and loss of terminal differentiation as a result of a lack of growth control (3, 4) . Homeostasis is based on three major forms of communication, extracellular communication via soluble factors which, secondly, triggers intracellular communication via second messengers and complex signal transductions pathways. These pathways may modulate the third form of communication, gap junctional intercellular communication (GJIC) . Disruption of one of these can promote the multistep process of (photo)carcinogenesis (5) .
As to cellular cross-talk, the most direct pathway is provided by gap junctions, cell-to-cell channels connecting the cytoplasm of neighboring cells and thereby permitting the direct diffusion of ions and small (51200 Da) molecules (metabolites, cofactors, second messengers, etc.). Each gap junction channel is comprised of two hemichannels or connexons, each formed by the aggregation of six protein subunits belonging to the connexin (Cx) multigene family (5, 6) .
In human skin, the two most abundant Cxs are Cx26 and Cx43. While Cx26 is mainly expressed in the epidermal basal layer, Cx43 is expressed in dermal fibroblasts and throughout spinous and granular cell layers of the epidermis, but also focally in the basal layer (7, 8) . Cx26 and Cx43 are differentially expressed in keratinocytes during development of the epidermis (9) . Furthermore, GJIC is beneficial in regulation of epidermal wound repair, facilitating synchronization of the contractile forces within granulation tissue during wound contraction (10) . Conversely, in vivo and in vitro studies confirmed the disruption of GJIC in basal and squamous cell carcinomas (11±13). The surrounding non-neoplastic cells (stromal cells), if tumor cells invade the underlying connective tissue, were not addressed in these studies.
Tumor±stroma interaction is important in melanoma and skin carcinoma development. Tissue invasion as part of tumor progression requires multiple interactions of the tumor cells with the surrounding stroma (14) . In that context, it was shown convincingly that paracrine acting factors resulted in both the expression and activation of distinct members of the serine protease and matrix metalloproteinase (MMP) family and enhancement of angiogenesis as prerequisites of tumor invasion (15, 16) . However, the mechanisms underlying an increase in or inhibition of intercellular communication of malignant keratinocytes with surrounding stromal cells (heterologous GJIC ) have not yet been examined. Recently, an increase in Cx43-derived GJIC of glioma cells and stromal astrocytes was demonstrated to contribute to glioma invasion (17) .
In the present study, we address the questions of whether there are direct cellular interactions mediated by gap junctions between a malignant SCC cell line and dermal fibroblasts or whether skin-derived tumor cells may modulate GJIC of these fibroblasts. To explore these possibilities in a controlled and easily accessible model, we developed an in vitro tumor/ stroma' system in which the human malignant squamous cell line SCL-1 (18) and fibroblasts were co-cultured and grew as monolayers. Using a combined biochemical and molecular biological approach, we report not only a deficiency of GJIC between the tumor cells and the (stromal) fibroblasts (heterologous GJIC), but, interestingly, also that a paracrine acting factor(s) constitutively secreted by the squamous cell line down-regulates intercellular communication between fibroblasts (homologous GJIC) via an increase in intracellular calcium concentration. These data suggest that inhibition of both homologous and heterologous GJIC may support invasion of cancer cells by blocking growth inhibitory or proapoptotic stimuli from neighboring normal cells.
Materials and methods

Materials
Cell culture media [Dulbecco's modified Eagle's medium (DMEM) and keratinocyte-SFM medium plus supplements] and TriFast TM reagent were purchased from Invitrogen GmbH (Karlsruhe, Germany) and peqlab Biotechnologie GmbH (Erlangen, Germany), respectively, and the defined fetal calf serum (FCS gold) was from PAA Laboratories (Linz, Austria). All chemicals and biochemicals were obtained from Sigma unless otherwise indicated. Mitogen-activated protein kinase/extracellular regulated kinase 1/2 (MEK1/2) inhibitor U0126 was supplied by Merck Biosciences (Schwalbach, Germany). The protein assay kit (Bio-Rad DC) was from Bio-Rad Laboratories GmbH (M unchen, Germany). Rabbit polyclonal antibody against human Cx43 and mouse monoclonal anti-human cytokeratin (CK) (Pan) were supplied by Sigma (Deisenhofen, Germany) and Zytomed (Berlin, Germany), respectively. Polyclonal horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (H L) antibody used in western blot analysis was obtained from Dianova (Hamburg, Germany). For immunocytochemistry Alexa 546-coupled goat anti-rabbit IgG (H L), Alexa 488-coupled goat anti-mouse antibody (H L) and Alexa 488-coupled phalloidin were from Molecular Probes (MoBiTec GmbH, G ottingen, Germany). The ECL Western Blotting kit used to detect mouse and rabbit primary antibodies on western blots in combination with HRPconjugated secondary antibodies was supplied by Amersham Biosciences (Freiburg, Germany). Superscript II RNase H-Reverse Transcriptase and HotStarTaq DNA Polymerase were purchased from Invitrogen and Qiagen (Hilden, Germany), respectively. The ultrafiltration devices Centriprep YM-10 [10 kDa molecular weight cut-off (MWCO)] and YM-30 (30 kDa MWCO) were supplied by Millipore GmbH (Schwalbach, Germany), Vivaspin 20 filter unit (20 kDa MWCO) was obtained from Vivascience AG (Hannover, Germany).
Cell culture
Human dermal fibroblasts (HDF) were established by outgrowth from foreskin biopsies of healthy donors (19) with an age of 3±6 years. Cells were used at passages 2±10, corresponding to cumulative population doubling levels of 3±21 (20) . Normal human epidermal keratinocytes (NHEK) were prepared from circumcised foreskin based on a protocol described earlier (21) and cultures were maintained in keratinocyte-SFM medium supplemented with 0.09 mM calcium, 35 mg/ml bovine pituitary extract, recombinant epidermal growth factor (0.2 ng/ml) and 5 mg/ml gentamycin. Subconfluent NHEK (~75% confluence) were subcultured as described by the manufacturer and were used for the experiments at passages 2±6. Dermal fibroblasts and the SCC line SCL-1, originally derived from the face of a 74-year-old woman (18) (generously provided by Dr Norbert E.Fusenig, DKFZ Heidelberg, Germany), were maintained in DMEM supplemented with glutamine (2 mM), penicillin (400 U/ml), streptomycin (50 mg/ml), 10% defined fetal calf serum (FCS) in a humidified atmosphere of 5% CO 2 and 95% air at 37 C. For co-cultures of dermal fibroblasts and SCL-1 tumor cells, the cells were grown on 3.5 cm diameter tissue culture dishes at ratios (HDF:SCL-1) of 1:1, 2:1 or 3:1. These ratios did not change the morphology of the fibroblasts or the tumor cells.
Gap junctional communication assay (Lucifer Yellow transfer)
In initial experiments, confluent HDF/SCL-1 co-cultures, confluent HDF monolayer cultures and subconfluent (~70% confluence) or confluent SCL-1 cell cultures were maintained in DMEM 10% FCS throughout the experiments. In subsequent experiments, serum-free supernatants of confluent fibroblasts, called`conditioned medium', and subconfluent SCL-1 cells were harvested after 48 h and put on confluent HDF monolayer cultures which were grown in complete DMEM 10% FCS. Prior to addition of the supernatants, serum-containing medium was removed and the cells were washed with phosphate-buffered saline (PBS). At different time points thereafter, the cells were used for microinjection. GJIC was measured by microinjection of the fluorescent dye Lucifer Yellow CH (10% in 0.33 M LiCl) into selected fibroblasts or tumor cells by means of a micromanipulator and a microinjector system (Eppendorf, Hamburg).
In co-culture experiments, only those fibroblasts and SCL-1 cells were microinjected which have been surrounded by other cells of the same type. One minute after injection, the number of fluorescent cells around a single cell loaded with the dye were counted. Ten individual cells per dish were injected and medians, 25% quartiles and 75% quartiles were calculated (see below). Images were taken with a Zeiss Axiovert fluorescence microscope with a charge coupled device (CCD) camera (ORCA II; Hamamatsu, Herrsching, Germany).
Immunocytochemistry
For immunocytochemistry, confluent co-cultures, confluent HDF cells, subconfluent NHEK and confluent SCL-1 monolayer cultures were grown in complete medium with FCS or keratinocyte medium supplement on coverslips in 3.5 cm diameter culture dishes before use. Cells were washed with PBS and fixed with methanol for 10 min at À20 C or 3.7% formaldehyde/PBS (F-actin staining) for 10 min at room temperature. Thereafter the cells were incubated for 3 min with 0.1% Triton X-100/PBS (F-actin staining). After washing with PBS, non-specific binding of antibodies was blocked with 3% normal goat serum (NGS) in PBS containing 0.3% (v/v) Triton X-100 for 45 min at room temperature. Cells were incubated with a polyclonal anti-Cx43 antibody or a combination of anti-Cx43 and anti-CK, both diluted 1:1500 in 1% (v/v) NGS/ PBS overnight at 4 C. Thereafter, cells were washed three times with PBS and incubated with an Alexa 546-coupled goat anti-rabbit IgG (1:800 diluted in PBS) and/or Alexa 488-conjugated goat anti-mouse IgG (1:1000 diluted in PBS) for 45 min at 37 C. For double staining of Cx43 and F-actin, cells were incubated with an Alexa 546-coupled goat anti-rabbit IgG and Alexa 488-phalloidin (1:80 diluted in PBS, 200 U/ml stock), respectively, for 30 min at 37 C. For DAPI staining, cells were incubated for 10 min at room temperature with 1:1000 diluted DAPI solution (stock solution 0.5 mg/10 ml H 2 O) in McIlvaine's buffer (100 mM citric acid, 200 mM Na 2 HPO 4 , pH 7.2). After washing and embedding, images were taken with a Zeiss Axiovert fluorescence microscope coupled to a CCD camera (ORCA II).
Protein fractionation (ultrafiltration)
Prior to ultrafiltration, precooled (4 C) cell culture supernatants were filtered through a 0.2 mm syringe filter to remove any cellular debris. Ultrafiltration of tumor cell supernatants with Centriprep YM-10 (10 kDa MWCO) at 1500 g (4 C) resulted in a 410 kDa retentate. This concentrated retentate was brought to the original volume with serum-free medium and thereafter filtrated through Centriprep YM-30 (30 kDa MWCO) at 1500 g (4 C), resulting in a 410±530 kDa filtrate and a 430 kDa fraction. The filtrate was spun down with Vivaspin 20 (5000 g, 4 C) and a concentrated 420±530 kDa fraction was obtained which was brought to the original volume with serum-free medium or PBS, 5 mM glucose, 20 mM CaCl 2 buffer. All fractions were tested for biological activity concerning modulation of intercellular communication.
Reverse transcriptase±polymerase chain reaction (RT±PCR)
Total RNA was extracted using the TriFast TM reagent according to the manufacturer's protocol. Reverse transcription of 1 mg of total RNA was performed in a volume of 20 ml for 1 h at 42 C using 100 U Superscript II RNase H-Reverse Transcriptase in 50 C for 60 s, followed by an incubation of 10 min at 72 C. The PCR products (727 bp for Cx43, 440 bp for HPRT) were analyzed on a 1.0% agarose gel which contained 10 mg/ml ethidium bromide in 0.5Â Tris±borate/EDTA buffer. Densitometric analysis was performed using Scion Image software (Scion Corp., Frederick, MD). Densitometric data were standardized to HPRT fragment and represent x-fold increase over Cx43 mRNA level of fibroblasts incubated with conditioned medium, which was set at 1.0.
SDS±polyacrylamide gel electrophoresis (SDS±PAGE) and western blot analysis SDS±PAGE was performed according to the standard protocols published elsewhere (22) , with minor modifications. Briefly, cells were lysed in 2Â SDS±PAGE buffer (125 mM Tris±HCl, 4% w/v SDS, 20% w/v glycerol, 100 mM dithiothreitol, pH 6.8). After sonication, the protein amount of the samples was determined using a modified Lowry method (Bio-Rad DC). Thereafter, bromophenol blue was added (0.1% final concentration), the lysates were heated for 5 min at 95 C and the samples (10 mg total protein/lane) were applied to 10% (w/v) SDS±polyacrylamide gels. After semi-dry blotting to nitrocellulose filters (Schleicher & Schuell, Dassel, Germany), the filters were incubated with a 1:1000 dilution of primary antibody (rabbit polyclonal anti-human Cx43) and a 1:5000 dilution of anti-rabbit secondary antibody conjugated to HRP. Antigen±antibody complexes were visualized by enhanced chemiluminescence (ECL) and exposed to Hyperfilm-ECL (Amersham Biosciences). Densitometric analysis was performed using Scion Image software.
Measurement of intracellular Ca 2 concentration [Ca 2 ] i
Human dermal fibroblasts were grown to confluence on coverslips in 3.5 cm diameter culture dishes in phenol red-free DMEM plus supplements. Cells were washed with FCS-free DMEM and loaded with 5 mM Fura-2/acetoxymethyl ester for 30 min. After the loading period extracellular dye was removed and the coverslips were fixed in a perfusion chamber on an inverted fluorescence microscope (Zeiss, Oberkochen, Germany) and covered with conditioned medium resulting in a total bath volume of 200 ml. Cells were then alternately excited at 340 and 380 nm, respectively, for up to 30 min at a rate of 2 Hz by a monochromator, and emission was detected at 480±520 nm using a CCD camera as provided by the QuantiCell 2000 Ò calcium imaging set-up (VisiTech, Sunderland, UK). [Ca 2 ] i is given as the ratio of the fluorescence measured at 340 (bound calcium) and 380 nm (free calcium) excitation wavelengths. After~5 min, 100 ml of a 3-fold concentrated fraction of tumor cell-derived supernatant was added. At the end of each experiment 10 ml of a 100 mM ATP solution was instilled, resulting in a final concentration of 3.2 mM ATP.
Statistical analysis
In order to quantify the distribution of the number of communicating cells, box-and-whisker plots (box plot) were used which highlight and combine important parameters describing the scatter of the sample data: the median (line inside the box), 25% quartile (lower boundary of the box), 75% quartile (upper boundary of the box) and minimum and maximum values (vertical lines from the box,`whiskers'). In this study, box plots indicate a non-Gaussian distribution because the medians are not located in the middle of the box, the whiskers of a box are different in length and the boxes are of different sizes (inhomogeneity of the variances). Therefore, for analysis of statistical significance, non-parametric tests such as the Mann±Whitney test, Wilcoxon test and Kruskal±Wallis test were applied (23) . Before the study P 5 0.05, P 5 0.01 and P 5 0.001 were selected as the levels of significance; P 4 0.05 indicated no significance.
Results
Cx43 protein in dermal fibroblasts, epidermal keratinocytes and epithelial tumor cells
The distribution of Cx43 protein within human dermal fibroblasts ( Figure 1A ), NHEK cells ( Figure 1D ) and SCC cell line SCL-1 ( Figure 1G ) was investigated by immunostaining. In confluent human dermal fibroblasts Cx43 proteins were localized at the cell membrane, with some protein signal detectable within the cytoplasm ( Figure 1A ). Figure 1B represents staining of the nuclei of the cells of Figure 1A . In contrast to confluent fibroblasts, only subconfluent NHEK cells showed Cx43 proteins located at the plasma membrane ( Figure 1D ). In addition, a bright fluorescence within the cytoplasm, but only close to the nuclei ( Figure 1E ), was detectable in normal keratinocytes, suggesting a higher amount of Cx43 protein within the cytoplasm ( Figure 1D ). Confluent and differentiated NHEK alter the expression pattern of their Cxs (8, 9) . Accordingly, Cx43 was not detected in confluent keratinocyte monolayer cultures (unpublished data). Localization of Cx43 protein at the cell membrane of fibroblasts as well as subconfluent keratinocytes suggests intercellular communication within both these non-tumorigenic cell types.
In comparison with confluent fibroblasts or subconfluent normal keratinocytes, in subconfluent (unpublished data) and confluent SCC SCL-1 cell cultures almost no Cx43 protein was translocated to the cell membrane. Rather, these cells showed a bright Cx43 fluorescence close to the nucleus ( Figure 1G ). This aberrant localization of Cx43 indicated an abrogated GJIC between the tumor cells, which has been described as a landmark of malignant transformation (5) .
Furthermore, a tight network of specific CKs was detected in SCL-1 cells ( Figure 1H ) which did not exist in fibroblasts ( Figure 3B ). The antibody cocktail (Pan) used in this study recognizes, for example, CK4, CK5, CK6, CK10, CK13 and CK17, which identify the putative tissue origin of a (metastatic) carcinoma (24, 25) . Figure 1C , F and I show the characteristic morphology of confluent dermal fibroblasts, subconfluent epidermal keratinocytes and confluent SCL-1 tumor cells.
Down-regulation of GJIC between dermal fibroblasts co-cultured with squamous tumor cell line SCL-1 In order to study GJIC between (stromal) fibroblasts during tumor±stroma interaction, dermal fibroblasts were co-cultured with SCL-1 tumor cells. Measurements of GJIC between fibroblasts by microinjection of Lucifer Yellow dye into selected fibroblasts, which were surrounded by cells of the same cell type, were performed with confluent co-cultures maintained in medium containing 10% FCS (Figure 2 ). Comparing the medians of the box plots, co-cultures of fibroblasts with tumor cells at different ratios ( Figure 2C ) resulted in a 52±70% lowering of the number of communicating fibroblasts compared with pure fibroblast monolayer cultures ( Figure 2A ) (P 5 0.0001). The middle 50% of the values (interquartile range) indicated by the box length ranged between 10.0 and 19.0 for fibroblast monolayer cultures, while the values for the co-cultures were significantly lowered, ranging between 3.0 and 7.0 and between 4.0 and 8.0, respectively. In contrast to pure fibroblast cultures, microinjected SCL-1 tumor cells ( Figure 2C ) were unable to transfer dye to neighboring SCL-1 cells or fibroblasts.
Next, we addressed the question of whether the distribution of Cx43 protein between human dermal fibroblasts is modulated by tumor cells in the co-culture system. Fibroblast monolayer cultures served as controls and showed a typical Cx43 distribution at the cell membrane ( Figure 3A) . Interestingly, the Cx43 distribution at the cell membrane of the fibroblasts was not changed in the presence of SCL-1 cells, which was independent of the investigated fibroblast/tumor cell ratios ( Figure 3D ).
To distinguish fibroblasts and tumor cells in the co-culture system, cytokeratin staining was performed. In contrast to fibroblasts used as negative controls ( Figure 3B ), SCL-1 tumor cells showed a bright cytokeratin staining in the coculture system ( Figure 3E ). Figure 3C and F represent DAPI stained nuclei of the cells shown in Figure 3A and D. The morphology of the confluent fibroblasts ( Figure 3H ) did not change in the co-culture system ( Figure 3G ). In evidence, the tumor cells (t) grew in clusters between the (stromal) fibroblasts (f ) ( Figure 3G ).
Tumor cell-dependent down-regulation of homologous GJIC of fibroblasts Data obtained from co-culture experiments suggested paracrine modulation of GJIC communication between fibroblasts via squamous cell line SCL-1. To test this hypothesis, serumfree (±FCS) and serum-containing (FCS) supernatants of subconfluent SCL-1 monolayer cultures were harvested after 1 or 2 days and added to fibroblast monolayer cultures for 24 h. As controls, serum-free and serum-containing conditioned medium was harvested after 1 or 2 days and added to confluent fibroblasts which were subjected to gap junctional communication assays ( Figure 4A ). In comparison with these controls (±FCS, median 8.5; FCS, median 9.0), confluent fibroblasts incubated with both supernatants of the tumor cells exhibited an almost complete loss of GJIC (±FCS, median 0) or significant down-regulation of GJIC (FCS, median 5). Furthermore, the interquartile ranges (indicated by the box length) of the fibroblasts treated with supernatants of tumor cells were significantly different from the ranges of the appropriate controls treated with conditioned medium ( Figure 4A) . However, the use of serum-free tumor cell-derived supernatants resulted in a stronger down-regulation of homologous GJIC of fibroblasts compared with serum-containing supernatants. We hypothesize that the fetal calf serum contains a substance(s) which counteracts the observed effects and/or inhibits, at least in part, the appropriate soluble factor(s).
Supernatants harvested after 1 day showed similar results throughout the experiments (unpublished data). Additionally, supernatants of the human epidermoid carcinoma cell line A431 [European Collection of Cell Cultures (ECACC), Salisbury, UK] and human malignant melanoma cell line A375 (ECACC) showed identical results regarding down-regulation of GJIC between fibroblasts (unpublished data). No loss of cell viability was detected after treatment of dermal fibroblasts with tumor cell-derived supernatants (unpublished data). To exclude that acidification of the cell culture supernatants (26) is responsible for the observed results, prior to incubation of fibroblasts with conditioned medium or tumor cell-derived supernatants, the pH values of the two different supernatants were tested, both ranging between 7.4 and 7.5.
To estimate the relative molecular mass(es) of the biologically active factor(s) of tumor cell supernatants, commercially available membrane filter units were used. Using this fractionation assay, the molecular masses of the assumed paracrine acting factor(s) was measured to be between 20 and 30 kDa, herein called the 20/30 fraction, showing a significant downregulation of homologous GJIC of fibroblasts ( Figure 4B ). In comparison with the 520 kDa fraction (median 6) and 430 kDa fraction (median 7), the`active' 20/30 fraction resulted in medians ranging between 1 and 2. As heating of the 20/30 fraction (5 min at 90 C) prevented down-regulation of homologous GJIC of fibroblasts, we may speculate that the 20/30 fraction contains`active' protein(s).
Time course studies revealed that initiation of tumor cellmediated down-regulation of GJIC between fibroblasts was an early event (Table I) . Fibroblasts were incubated with serumfree conditioned medium harvested after 2 days [SN(2d) HDF] or serum-free supernatants of SCL-1 cells [SN(2d) SCL-1]. A significant down-regulation of GJIC was detected, starting 0.5±1 h after incubation with the supernatant of the tumor cells and persisting during the studied time period of 24 h. In experiments independent of the time course studies (Table I) , fibroblasts were treated for 48 h with tumor cell-derived supernatants. The GJIC down-regulating capacity of these supernatants was identical to the data observed after 24 h (unpublished data). While the medians of the number of communicating fibroblasts used as controls ranged between 6.0 and 10.0 throughout the 24 h time interval, fibroblast monolayer cultures incubated with tumor cell supernatants showed significantly lowered medians ranging between 2.5 at 1.0 h and 0 at 24 h after incubation (Table I) .
Reversibility of homologous GJIC or its protection by selenite supplementation
In order to investigate reversibility of tumor cell-initiated down-regulation of GJIC between confluent fibroblasts, fibroblasts were incubated for 1.5 h with SN(2d) SCL-1 ( Figure 5) . A significant lowering of the number of communicating fibroblasts was observed (median 2.0) compared with fibroblast controls (median 7.0) incubated with SN(2d) HDF. Thereafter, supernatants of tumor cells were removed and replaced either by conditioned medium or fresh serum-containing culture medium. After incubation for a further 1.5 h, both approaches resulted in a significant increase in GJIC compared with the GJIC of fibroblasts incubated only with supernatants of tumor cells (P 5 0.01). The middle 50% of the values of the fibroblasts showing reversible GJIC ranged between 3.0 and 9.0, whereas the values of the fibroblasts incubated with the supernatants of the tumor cells were significantly lowered, ranging between 0 and 3.0 ( Figure 5) . Interestingly, the strongest effect on the increase in the number of communicating fibroblasts after removal of tumor cell supernatants was mediated by the serum-containing culture medium compared with the fibroblast-derived (conditioned) medium, suggesting an influence of a (soluble) factor(s) which may not be secreted by fibroblasts.
Since epidemiological studies and human clinical intervention trials support a protective role of selenium against cancer development (27) and Sharov et al. (28) convincingly showed protection of gap junctional communication from peroxynitrite by selenite supplementation, we addressed the question of whether selenite supplementation protects dermal fibroblasts from tumor cell-mediated down-regulation of homologous GJIC. Therefore, confluent fibroblast monolayer cultures were incubated with a non-toxic concentration of sodium selenite (29) prior to treatment with supernatant of tumor cells or conditioned medium (Figure 6 ). The presence of selenite had no effect on intercellular communication in control cultures. Interestingly, tumor cell-mediated down-regulation of GJIC between fibroblasts was significantly prevented after selenite supplementation compared with selenite-deficient fibroblast cultures, which was represented by the differences in the medians and interquartile ranges ( Figure 6 ).
Tumor cell-mediated down-regulation of GJIC between fibroblasts is independent of Cx43 expression and phosphorylation To investigate the molecular mechanisms underlying the above described down-regulation of GJIC between fibroblasts, confluent fibroblasts (HDF) preincubated for 24 h either with serum-free conditioned medium or serum-free supernatant of tumor cells were subjected to RT±PCR to determine supernatant-dependent effects on the level of transcription ( Figure 7A ). As a positive control, fibroblasts were stimulated with 1,25-dihydroxyvitamin D 3 (calcitriol) as described earlier (30) . In contrast to the calcitriol-stimulated cells (lane 3), showing a 1.8-fold increase in the steady-state Cx43 mRNA level, fibroblasts incubated with serum-free supernatants of SCL-1 tumor cells (lane 2) showed no significant alteration in Cx43 mRNA level (0.9-fold) compared with fibroblasts incubated for 24 h with serum-free conditioned medium (lane 1), indicating that tumor cell-triggered GJIC downregulation between fibroblasts seems to be independent of changes in Cx43 transcription.
In order to check tumor cell-dependent post-translational modifications of Cx43 protein in confluent dermal fibroblasts, the fibroblasts were incubated with either the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), GJIC modulation by squamous tumor cells capable of inhibiting GJIC by phosphorylation of Cx43 (31), or with their conditioned medium and tumor cell-derived supernatants, respectively ( Figure 7B ). An increased phosphorylation of Cx43 was detected in fibroblasts incubated with 100 mM TPA for 15 min (lane 3), as seen from shifts in electrophoretic mobility (P2) and a slight decrease in the amount of unphosphorylated protein (P0). The electrophoretic mobility shift is also demonstrated in densitometric scans ( Figure 7B , bottom). In contrast, for both fibroblasts treated with tumor cell supernatant (lane 2) and fibroblasts incubated with conditioned medium (lane 1) the phospho-Cx43 shift was prevented, indicating that tumor cell-mediated lowering in GJIC between fibroblasts may be independent of Cx43 phosphorylation.
To support this hypothesis, confluent fibroblasts were treated with a non-toxic concentration of the highly selective MEK1/2 inhibitor U0126 prior to incubation with U0126-containing tumor-cell derived supernatants ( Figure 7C ). U0126-containing SCL-1 supernatants (median 1.5) and SCL-1 supernatants without MEK1/2 inhibitor (median 0.5) led to similar significantly lowered communication rates between fibroblasts (P 4 0.05) compared with the high GJIC of control fibroblasts (median 12). Further, given that tyrosine phosphorylation was described to be an essential step in the blockade of gap junction communication (6) , the involvement of tyrosine phosphatases in reversibility of tumor cellinitiated down-regulation of GJIC between fibroblasts was studied. Therefore, SCL-1 supernatants were removed and replaced by fresh serum-containing culture medium or confluent fibroblasts were pretreated for an additional 1 h with tumor-cell derived supernatants containing a non-toxic concentration of sodium orthovanadate, a broad spectrum potent inhibitor of protein tyrosine phosphatases, prior to replacement of this supernatant by orthovanadate-and serum-containing culture medium ( Figure 7C ). Both orthovanadate-containing and orthovanadate-free medium resulted in a significant increase in GJIC compared with the GJIC of fibroblasts incubated only with supernatants of tumor cells (P 5 0.001).
Calcium influx modulates homologous GJIC of fibroblasts
To study a potential effect of a paracrine factor(s) on intracellular calcium concentration of confluent fibroblasts, 5 mM EGTA was added to SCL-1 supernatants prior to incubation of fibroblasts for 1 h. In contrast to EGTA-free SCL-1 supernatants, the number of communicating fibroblasts was significantly increased, obtaining nearly identical levels as fibroblasts incubated with conditioned medium (Figure 8A 
Discussion
The carcinogenic process involves the transition from a normal, GJIC-competent cell to one which is defective in GJIC, finally resulting in breakdown of intercellular communication between tumor cells during tumor promotion (5, 34, 35) . However, the Cx status during tumor±stroma interaction and GJIC between (stromal) fibroblasts and tumor cells or between fibroblasts or tumor cells alone have not been widely studied. The understanding of the molecular mechanisms during tumor progression is crucial for the design and effective use of novel therapeutic strategies to combat invasion and metastasis. In our studies regarding tumor±stroma interaction, we established an in vitro tumor±stroma model using the SCC cell line SCL-1 and dermal fibroblasts in co-culture. This model roughly represents the in vivo situation of SCC invasion described elsewhere (36, 37) .
In contrast to fibroblast monolayer cultures showing a high level of gap junction-mediated communication herein and also described earlier (38) , this type of homologous cell±cell communication was abrogated in the squamous cell line SCL-1. These results perfectly fit with the hypothesis that the Cx gap junction proteins appear to act as tumor suppressors and that their tumor inhibitory effect is usually attributed to their main function of cell coupling through gap junctions (35) . In that context, it was obvious that the communication with cells of another type (heterologous GJIC) may be inhibited (35) , which was confirmed by co-cultures of SCL-1 with (stromal) fibroblasts. Immunostaining, RT±PCR and western blot analysis revealed that the decrease in homologous and heterologous GJIC of SCL-1 tumor cells is not due to down-regulation of Cx43 expression, but rather to the aberrant localization of Cx43 in the cytoplasm near the nucleus, as described elsewhere (35, 39) . Interestingly, a significant down-regulation of homologous cell±cell communication of fibroblasts was observed in our co-culture system, indicating that tumor cells may exert a commanding influence on the surrounding stromal cells regarding GJIC. Such an influence of tumor cells on the surrounding cells was described for the expression of cell adhesion molecules and proteolytic enzymes as prerequisites for tumor malignancy (16, 40) . Evidence has been provided that the secretion of tumor-derived soluble factors (i.e. cytokines and growth factors) play an important role in the induction of stromal proteases (14, 41) . Therefore, we tested the effect of soluble factors derived from different tumorigenic cell lines on intercellular communication between fibroblasts seeded as monolayer cultures. Our data convincingly show that one or more soluble factors appears to be responsible for down-regulation of homologous GJIC of the fibroblasts. Studies are underway to identify the factor(s).
Furthermore, homologous GJIC of SCL-1 tumor cells in coculture with dermal fibroblasts was almost completely abrogated, indicating that surrounding fibroblasts did not affect GJIC between the tumor cells. In contrast to our findings, evidence exists that the inhibition of neoplastic cell growth in co-culture with their normal counterparts is mediated via GJIC. For example, growth suppression of the oncogenetransformed C3H 10T1/2 mouse fibroblast cell line (42) or oncogene-transformed WB-F344 rat liver epithelial cells (43) was mediated by their highly communicating, non-transformed counterparts and involved an increase in GJIC between transformed and non-transformed cells. In addition, King et al. (44) reported that the ability of Cx43-positive clones of the cervical cell line HeLa to proliferate was greatly diminished via GJIC in the presence of a confluent mouse or human fibroblast monolayer culture. In that context, the question arises whether highly aggressive and metastatic squamous cell carcinoma cells or melanoma cells protect themselves from the above described (43, 44) homologous and heterologous GJIC during tumor invasion, as described in this study.
Given that the herein described homologous GJIC blockade occurred early upon treatment with the paracrine acting factor(s), post-translational modifications of the Cx43 protein seem to be responsible for the observed effects, rather than a decrease in Cx43 expression. The importance of a balance between protein phosphorylation (45) and dephosphorylation (46) initiated by growth factors (6) , resulting in Cx trafficking, assembly and disassembly, as well as modulation of the open state of junctional channels, has progressively gained support over recent years. However, neither modulation of Cx43 expression or localization nor modulation of the Cx43 phosphorylation state was measured in our study, suggesting that this tumor cell-mediated down-regulation of intercellular communication between fibroblasts might be independent of protein kinases, e.g. mitogen-activated protein kinases or tyrosine kinase pp60 src , which normally play a role in closure of gap junctions (6, 47) .
Another mechanism regulating channel gating includes intracellular levels of calcium ions (31, 48) . Calcium, acting as a second messenger in different signaling pathways, plays a critical role in numerous physiological and pathological processes. For example, calcium is a key regulator of keratinocyte function during epidermal differentiation (49) , and coordinated cell±cell adhesion of fibroblasts via recruitment of cadherins and catenins to the actin cytoskeleton is essential for connective tissue remodeling and wound healing (50) . In contrast, increasing extracellular and intracellular calcium concentrations enhanced cellular proliferation and MMPdependent migration/invasion of oral SCC (51) .
Our studies have shown that a tumor cell-derived soluble factor(s) increases intracellular calcium concentration in fibroblasts which resulted in closure of gap junctions and disruption of homologous intercellular communication of fibroblasts, as indicated by dye transfer. It is less clear how calcium regulates gap junction channel permeability. Recently, the importance of functional hemichannels (connexons) was not only described for transduction of cell survival signals (52) and ATP release (53) , but also for low extracellular calcium concentrations (53) . In contrast, the hemichannels are closed within a range of high extracellular calcium concentrations (1±2 mM) (53, 54) , which reflect the concentration in the cell culture medium. Taken together, we may speculate that functional hemichannels play no role or an unimportant one in the tumor cell-mediated down-regulation of gap junctiondependent communication between fibroblasts. However, published data suggest that calcium may act on the gap junction channel itself. Even though both the C-and N-termini of Cx proteins do not possess putative calcium-binding sites in their sequence, it was shown by a cysteine mutant (Cx46L35C) that position 35 of the first transmembrane segment of Xenopus Cx46 is responsible for direct calcium-mediated channel closure (54, 55) .
In addition to these findings, the calcium-binding protein calmodulin (CaM) is associated with Cxs and this may be important in calcium-dependent intercellular communication. The role of CaM in channel regulation was studied in amphibian embryonic cells by using antisense oligonucleotides to CaM mRNA. The cells injected with the antisense molecules retained the capacity for GJIC under different experimental conditions (56) . Furthermore, two CaM-binding amino acid sequences in Cx32 provided evidence that CaM may function as an intracellular ligand, uncoupling Ca 2 -dependent intercellular communication across gap junctions (57) .
The finding in our study that a time delay exists between the tumor cell-mediated rapid increase in [Ca 2 ] i and downregulation of GJIC beween fibroblasts argues in favor of calcium acting as a second messenger. However, the soluble factor(s)-mediated down-regulation of GJIC in our model of tumor invasion was observed over a rather long time period and it cannot be excluded that both calcium-dependent cellular activities and direct calcium effects are involved in that GJIC inhibition. Further studies should prove this hypothesis. In summary, we here report a novel aspect of tumor± stroma interaction, namely that a paracrine acting factor(s) constitutively secreted by a malignant squamous cell line down-regulates homologous GJIC of fibroblasts via an increase in [Ca 2 ] i , which seems to be mediated by modulation of Ca 2 influx. Together with the loss of heterologous GJIC, these data suggest a mechanism by which tumor cells protect themselves from fibroblast-initiated apoptotic signaling. As invasion and metastatic spread of tumor cells continue to be the greatest barrier to curing cancer, an understanding of the cellular interaction between tumor cells and the surrounding stroma could assist us in the development of novel therapeutic strategies to combat metastasis more efficiently in the future. That micronutrients such as selenium or its metabolites might be a promising tool in that context was shown in a preliminary approach herein. Furthermore, selenium supplementation of patients with a history of basal cell or squamous carcinoma of the skin significantly reduced the overall cancer morbidity, as shown in a randomized controlled trial (58) .
